GSTM1 and anemia: Participants with anaemia (Hb < 10.5 g/dL) at < 18 weeks’ gestation had 2.79 times higher odds for having elevated MAP than women without anaemia (OR: 2.79, 95% CI: 1.15, 6.79) in model 2.